You have 9 free searches left this month | for more free features.

post-prandial insulin (PPI)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Post Prandial High Resolution Impedance- Manometry

Recruiting
  • Gastro-esophageal Reflux
  • Correlating the number of reflux episodes detected on 1-h post prandial esophageal high resolution manometry combined and those detected on ambulatory 24-h pH-impedance monitoring performed on PPI
  • Lyon, France
    Exploration Fonctionnelle Digestive, Hôpital Edouard Herriot, Ly
Mar 17, 2022

Dysglycemia Trial in Cork (MCE, Glucose)

Completed
  • Dysglycemia
  • MCE
  • Glucose
  • Cork, Ireland
    Atlantia Food Clinical Trials
Oct 17, 2022

Faba Bean, Post-prandial Blood Glucose, Appetite Trial in Winnipeg (Faba bean powder smoothie, Faba bean protein concentrate

Completed
  • Faba Bean
  • +4 more
  • Faba bean powder smoothie
  • +4 more
  • Winnipeg, Manitoba, Canada
    Richardson Centre for Functional Foods and Nutraceuticals
Jan 19, 2023

Healthy, Overweight Trial in Berlin (40 g Gum acacia (FibregumTM), 20 g Gum acacia (FibregumTM), 0 g Gum acacia (FibregumTM))

Completed
  • Healthy
  • Overweight
  • 40 g Gum acacia (FibregumTM)
  • +2 more
  • Berlin, Germany
    Analyze & Realize
Aug 17, 2020

Glucose Control in Participants With Type 1 and Type 2 Diabetes

Withdrawn
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Meal-Tagging App and Web-based Portal:
  • Fitness Tracker
  • Boston, Massachusetts
  • +1 more
Sep 10, 2021

Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Saint Louis (Insulin)

Terminated
  • Type 1 Diabetes
  • Hyperglycemia, Postprandial
  • Saint Louis, Missouri
    Washington University in St Louis
Sep 13, 2022

Type 1 Diabetic Post Prandial Glycemia Evaluation UsingAlgorithm

Active, not recruiting
  • Type I Diabetes
  • Measure of glycemia levels and comparison to algorithm predictions
  • Marseille, France
  • +1 more
Aug 23, 2022

Obesity, Appetitive Behavior Trial in La Plata (food (breakfast))

Completed
  • Obesity
  • Appetitive Behavior
  • food (breakfast)
  • La Plata, Buenos Aires, Argentina
    Instituto de Desarrollo e Investigaciones Pediátricas (IDIP)
Apr 4, 2023

Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))

Completed
  • Type 2 Diabetes Mellitus
  • Postprandial Hyperglycemia
  • Insulin aspart (Novorapid®)
  • Stockholm, Sweden
    Department of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022

Technology to Improve Glucose Control in Type 1 Diabetes

Completed
  • Diabetes Mellitus, Type 1
  • Meal-Tagging App
  • Fitness Tracker
  • Boston, Massachusetts
    Joslin Diabetes Center
Aug 20, 2020

Type II Diabetes Trial in Lisieux (PAZ320, Placebo)

Withdrawn
  • Type II Diabetes
  • Lisieux, Normandy, France
    Department of Internal Medicine, Infectious Diseases and Diabeto
Sep 24, 2020

Type2 Diabetes Trial in Padova (ABO-GLYC, ABO-GLYC Placebo)

Completed
  • Type2 Diabetes
  • ABO-GLYC
  • ABO-GLYC Placebo
  • Padova, Italy
    Azienda Ospedaliera Padova
Jun 28, 2022

Metabolic Diseases Trial in Roanoke (Ultra-processed food - Picture Set Meal, Ultra-processed food - Additives Meal,

Recruiting
  • Metabolic Diseases
  • Ultra-processed food - Picture Set Meal
  • +5 more
  • Roanoke, Virginia
    Fralin Biomedical Research Institute at VTC
Aug 24, 2023

Type 2 Diabetes Trial in India (INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010), INSULIN GLARGINE (HOE901), Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)
  • +3 more
  • Bangalore, India
  • +12 more
Apr 21, 2022

Healthy, PreDiabetes, Adult Trial (Blood collection)

Not yet recruiting
  • Healthy
  • +3 more
  • Blood collection
  • (no location specified)
Oct 5, 2022

Hyperglycemia, Renal Transplant Complication Primary Non-Function, Diabetes Trial (Semaglutide 14 MG [Rybelsus], Placebo)

Not yet recruiting
  • Hyperglycemia
  • +2 more
  • Semaglutide 14 MG [Rybelsus]
  • Placebo
  • (no location specified)
Feb 1, 2023

Dietary Supplement Trial in Tustin (Oligomalt, maltodextrin)

Completed
  • Dietary Supplement
  • Oligomalt
  • maltodextrin
  • Tustin, California
    Orange County Research Center
Jul 26, 2023

Postbariatric Hypoglycemia Trial in Aurora (Mizagliflozin)

Recruiting
  • Postbariatric Hypoglycemia
  • Aurora, Colorado
    University of Colorado / Anschutz Medical Campus
Sep 12, 2022

Diabetes Prevention, Obesity Prevention Trial in Winnipeg (Control, Small particle size pea flour, Large particle size pea

Completed
  • Diabetes Prevention
  • Obesity Prevention
  • Control
  • +5 more
  • Winnipeg, Manitoba, Canada
    Richardson Centre for Functional Foods and Nutraceuticals
Jan 19, 2023

Gastro-esophageal Reflux Disease Trial in France (Upper gastrointestinal (GI) endoscopy, Wireless pH monitoring, Post prandial

Recruiting
  • Gastro-esophageal Reflux Disease
  • Upper gastrointestinal (GI) endoscopy
  • +3 more
  • Chambray-lès-Tours, France
  • +6 more
May 5, 2021

Dietary Supplement Trial in Tustin, Singapore (Dietary Supplement: Sprinkled Format REDUCOSE., Reference control, Active

Completed
  • Dietary Supplement
  • Dietary Supplement: Sprinkled Format REDUCOSE.
  • +2 more
  • Tustin, California
  • +1 more
Feb 2, 2022

Diabetes, Type 1 Trial in Aurora (Technosphere insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Technosphere insulin
  • Aurora, Colorado
    Barbara Davis Center
Jan 28, 2022

Diabetes Trial in Roma (inulin, standard therapy)

Recruiting
  • Diabetes
  • inulin
  • standard therapy
  • Roma, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Apr 1, 2023

Pediatric Obesity, Meal Timing Trial in Los Angeles (Meal-timing)

Recruiting
  • Pediatric Obesity
  • Meal Timing
  • Meal-timing
  • Los Angeles, California
    Children's Hospital Los Angeles
Nov 14, 2022

Metabolic Syndrome, Diabetes, Diet Modification Trial (autoclaved BSG-containing biscuits, bio-transformed BSG-containing

Not yet recruiting
  • Metabolic Syndrome
  • +2 more
  • autoclaved BSG-containing biscuits
  • +2 more
  • (no location specified)
Jun 13, 2022